openPR Logo
Press release

Global Multiple Sclerosis Drugs Market Insights, forecast to 2026 by Valuates Reports

06-19-2019 02:11 PM CET | Health & Medicine

Press release from: Fortune Business Insights

Global Multiple Sclerosis Drugs Market Insights, forecast

The Global Multiple Sclerosis Drugs Market is expected to gain from the development of economical therapy to treat multiple sclerosis (MS), finds Fortune Business Insights in a report, titled “MULTIPLE SCLEROSIS DRUGS: GLOBAL MARKET ANALYSIS, INSIGHTS AND FORECAST, 2019-2026.” According to the report, the global market was worth US$ 23,460.3 Mn in 2018. The market is anticipated to expand at a CAGR of 6.7% and reach US$ 39,289.5 Mn by the end of 2026. The report offers a comprehensive overview of the global multiple sclerosis drugs market.

Sample PDF Brochure at https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/multiple-sclerosis-drugs-market-100386

Some of the major companies that are present in the Global Multiple Sclerosis Drugs Market are;

• Biogen
• Pfizer, Inc.
• Roche
• Merck & Co., Inc.
• Novartis
• Sanofi
• Teva Pharmaceutical
• Other players

As per the report, North America emerged dominant in the global market in 2018. The regional market was valued at US$ 13,826.7 Mn in 2018. The North America market is anticipated to expand and continue dominate the market during the forecast period 2019-2026. It is driven by the increasing demand for and high price of multiple sclerosis drugs. Additionally, several key market players operate in this region. Several among them are awaiting approval from the authorities for their newly developed therapeutics. This is expected to increase the growth rate in the global market. Europe is anticipated to stand second on the leading list by the end of 2026. The growth witnessed is attributable to increasing government spending and recommendations for multiple sclerosis treatment. This is expected to fuel the demand in the region. Besides this, Asia Pacific is anticipated to expand at the highest CAGR during the forecast period. Healthcare sector emerging in nations such as China and India is expected to contribute towards the Asia Pacific market expansion.

In 2018, Biogen collaborated with Eisai Co. Ltd. to promote Tecfidera, Tysabri, and Avonex in Japan. This is anticipated to increase the demand in the global market.

Development of New Therapeutics to Propel Growth

In terms of route of administration, the injection segment was leading the market in 2018 and is anticipated to expand considerably over the forecast period. The growth witnessed is attributable to the active government recommendation for the injection.

Development of new therapeutics for treating multiple sclerosis and rising awareness about the disease are expected to drive the global Multiple Sclerosis Drugs Market. Additionally, increasing per-capita income and increasing healthcare expenditure are some factors anticipated to fuel the demand in the global market.

On the flip side, high cost associated with multiple sclerosis drugs and treatment and lack of availability of drugs are factors that may hamper the growth in the global market.

Major Table of Content Multiple Sclerosis Drugs Market are;

4. Key Insights
4.1 Prevalence of Multiple Sclerosis - For Key Countries, 2018
4.2 Regulatory Scenario - For Key Countries
4.3 Patent Snapshot
4.4 New Drug Class Launch
4.5 Pipeline Analysis
4.6 Key Industry Developments - Mergers, Acquisitions and Partnerships

Tecfidera’s Increasing Sale to Drive Biogen’s Growth in Global Market

Biogen emerged as the leading player in the global multiple sclerosis market in 2018, owing to the high sales of Tecfidera. Biogen is expected to witness impressive growth during the forecast period gaining from strategical partnering with other players to widen the distribution network. Besides this, Novartis AG is also among the leading organizations. Owing to high demand for Gilenya, Novartis holds a strong position in the global market. In 2018, the National Institute for Health and Care Excellence announced to recommend Extavia among other beta interferon drugs such as Avonex, Betaferon and Rebif. This is anticipated to contribute towards Novartis’s market position. Further, this is anticipated to fuel the demand for multiple sclerosis treatment and drugs. Some of the companies operating in the global market are Pfizer, Inc., F. Hoffmann-La Roche Ltd, Merck & Co., Inc., Sanofi, and Teva Pharmaceutical Industries Ltd.

Browse Complete Report Details at https://www.fortunebusinessinsights.com/industry-reports/multiple-sclerosis-drugs-market-100386

Fortune Business Insights Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune - 411045, Maharashtra, India.

About us:

Fortune Business Insights offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights we aim at highlighting the most lucrative growth opportunities for our clients. We therefore offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Multiple Sclerosis Drugs Market Insights, forecast to 2026 by Valuates Reports here

News-ID: 1781176 • Views:

More Releases from Fortune Business Insights

Eventflare: Your Global Partner for Unique Corporate Events
Eventflare: Your Global Partner for Unique Corporate Events
𝐀 𝐍𝐞𝐰 𝐄𝐫𝐚 𝐨𝐟 𝐄𝐯𝐞𝐧𝐭 𝐏𝐥𝐚𝐧𝐧𝐢𝐧𝐠 Corporate events have evolved far beyond sterile hotel ballrooms and generic conference centres. Today, companies seek 𝐮𝐧𝐢𝐪𝐮𝐞, 𝐢𝐦𝐦𝐞𝐫𝐬𝐢𝐯𝐞 𝐯𝐞𝐧𝐮𝐞𝐬 that captivate attendees and reflect their brand's personality. Eventflare is redefining corporate event planning by offering a curated selection of extraordinary spaces, expert local knowledge, and seamless full-service event coordination in some of the world's most sought-after destinations. From industrial-chic lofts in Berlin to opulent historic villas
Sustainable Personal Care Products Market Share & Size Analysis, Growth, Trends, …
The global sustainable personal care products market size was valued at USD 54.36 billion in 2024. The market is projected to grow from USD 56.44 billion in 2025 to USD 90.40 billion by 2032, exhibiting a CAGR of 6.96% over the forecast period. Sustainable personal care products utilize eco-friendly materials and ethical manufacturing to reduce skin issues linked to sustainability. In response to growing consumer demand for sustainability, businesses are diversifying
Luxury Bedding Market Share & Size Analysis, Growth, Trends, Report, 2025-2032
The global luxury bedding market size was valued at USD 3.17 billion in 2024. The market is projected to grow to USD 4.32 billion by 2032, exhibiting a CAGR of 3.95% over the forecast period. Luxury bedding includes high-quality products such as duvets, quilts, mattresses, pillows, bed linens, and blankets, made from materials such as Egyptian cotton, linen, silk, and high-thread-count fabrics. These items offer exceptional comfort, durability, and a
Foam Concrete Market Outlook: Key Players, Growth Factors, Forecast 2032 | Companies- EUROCEMENT, LafargeHolicim, VOTORANTIM Group, Hochtief
Foam Concrete Market Outlook: Key Players, Growth Factors, Forecast 2032 | Compa …
The global foam concrete market size is projected to experience dynamic growth in the forthcoming years owing to the increasing number of residential complexes across the world, finds Fortune Business Insights™ in its report, titled "Foam Concrete Market, 2024-2032". The foam concrete is mainly used in the construction industry to build partition walls. This type of concrete is fire resistant and contains high thermal and acoustical insulating properties than conventional concrete.

All 5 Releases


More Releases for Multiple

Massive MIMO (Multiple-input multiple-output) Market 2022-2028 | Detailed Report
The market report delivers an all-inclusive analysis of the market structure along with a forecast of the various segments and sub-segments of the Massive MIMO (Multiple-input multiple-output) industry. This wide-ranging market research report acts as a backbone for the success of business in any niche. The Massive MIMO (Multiple-input multiple-output) market survey report has been prepared by conducting market research in a systematic manner. Moreover, the Massive MIMO (Multiple-input multiple-output)
Multiple Sclerosis Therapeutics Market – Increasing prevalence of multiple scl …
Multiple Sclerosis Therapeutics Market report is a exploration database spread across colorful runners with multiple tables and numbers in it. The exploration covers a precious source of perceptive information for business strategists. Multiple Sclerosis Therapeutics Industry provides the overview with growth analysis and literal & futuristic cost, profit, demand and force data (as applicable). The exploration judges give an elegant description of the value chain and its distributor analysis. This comprehensive
Global Multiple Sclerosis Market Size, Global Multiple Sclerosis Market Share, G …
The Global Multiple Sclerosis Market Size is majorly driven by the factors such as rising number of consolidations between the market players for exploring the untapped market opportunity across the world. Request for Sample of This Research Report @ https://bit.ly/2Nh6b4d Top Key Player:- Hoffmann-La Roche Ltd. Bayer Healthcare AG Teva Pharmaceuticals GlaxoSmithKline AbbVie Inc. Sonafi Pasteur Pfizer Inc. Merck & Company Novartis AG AB Science Opexa Multiple Sclerosis (MS) is a disease in which the insulating covers of nerves and spinal cord are
Multiple Ion Beam Microscopes Market- Multiple Ion Beam Microscopes Have Huge Ap …
An ion beam is a kind of charged particle beam which consists of ions. With the advancement of nanotechnology new and advanced fabrication techniques are required which helps in production of functional features in much smaller scales. Advanced techniques are being used for applications in material science which uses image surfaces producing different features in a nanoscale. Gas field ion source technology has the capability of combining helium and neon
Smart Antenna Market Report 2018: Segmentation by Type (Switched Beam Smart Ante …
Global Smart Antenna market research report provides company profile for Cobham Antenna Systems(Suffolk, United Kingdom), Intel Corp.( Santa Clara, California, United States), Samsung Electronics CoLtd. ( Seoul, South Korea), ArrayComm LLC ( California, United States), Alcatel-Lucent International Holdings Inc.( Paris, France), Motorola Solutions Inc.( Illinois, the U.S.) and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017,
Thermoseal Group Multiple Award Winners
For the second year in a row, Thermoseal Group is the winner of the coveted Glass and Glazing Industry’s G-Award for ‘Component Supplier of the Year’ as announced at the prestigious Gala Dinner held at the Hilton on Park Lane Hotel in London on Friday 18 November 2016. This was a great day for Thermoseal Group who were also announced winners at two other awards events held that day